Part, Chapter, Paragraph
1 I, 2. 10. 3| and digital technologies, test new solutions to speed up
2 II, 5. 1. 1| screening via PAP-smear test, these cells can be easily
3 II, 5. 3. 4| screening via PAP-smear test, these cells can be easily
4 II, 5. 3. 5| to the diffusion of PSA test in more affluent countries.
5 II, 5. 3. 5| 5.3.26) reflects the PSA test diffusion. Mortality rates
6 II, 5. 3. 7| earlier stage via screening test. The overall effectiveness
7 II, 5. 3. 7| the cervical smear or Pap test), and in randomised controlled
8 II, 5. 3. 7| faecal occult blood or FOB test). In Europe breast, colorectal
9 II, 5. 3. 7| European level. Pap smear test is able to detect cervical
10 II, 5. 9. 2| questionnaire, skin prick test, PRIST, RAST, spirometry
11 II, 5. 9. 4| sensitization (positive skin prick test to any of the tested inhalant
12 II, 5. 9. 4| as an in-vitro screening test for atopy) was 32.3%, with
13 II, 5. 11. 3| Varjonen E, Vuorela AM, Patch test reactions to cosmetic allergens
14 II, 5. 11. 3| Maibach, Prevalence of patch test results from 1970 to 2002
15 II, 5. 12. 5| cirrhosis and no diagnostic test or screening program which
16 II, 5. 15. 3| diagnosed through a biological test in Europe (mostly molecular).
17 II, 6. 4. 3| pandemics and smallpox) to test the execution of the national
18 II, 9. 3. 1| fewer women than men who test positive for heart disease
19 III, 10. 2. 1| programmes, pharmacies (predictor test), family planning centres,
20 III, 10. 2. 4| definitions: from “genetic test” to “genomic variant” to “
21 III, 10. 4. 2| also other aspects than test methods are considered.
22 III, 10. 5. 1| and Wyon 2007a). Moreover, test performance was increased
23 IV, 12. 10 | development project which works to test and document initiatives
24 IV, 13. 6. 3| United Nations, 1989). A core test of any health system is
25 IV, 13. 7. 1| support clusters and to test joint actions. In order
